This episode of the CCI Deep Dive Podcast examines one of the most aggressively marketed—and most misunderstood—areas in regenerative medicine: umbilical cord, amniotic, and placental “stem cell” products. Drawing from published scientific investigations, the discussion breaks down why many of these birth-derived products do not contain functional living stem cells despite bold clinical claims. The episode walks listeners through the hard data, the extremely low viability rates (35–75%)...
All content for Centeno-Schultz Clinic - Podcasts is the property of Centeno-Schultz Clinic Staff and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This episode of the CCI Deep Dive Podcast examines one of the most aggressively marketed—and most misunderstood—areas in regenerative medicine: umbilical cord, amniotic, and placental “stem cell” products. Drawing from published scientific investigations, the discussion breaks down why many of these birth-derived products do not contain functional living stem cells despite bold clinical claims. The episode walks listeners through the hard data, the extremely low viability rates (35–75%)...
CCI Deep Dive - Critical Questions You Need to Ask BEFORE Getting Neck Injections
Centeno-Schultz Clinic - Podcasts
12 minutes
2 weeks ago
CCI Deep Dive - Critical Questions You Need to Ask BEFORE Getting Neck Injections
In this CCI Deep Dive episode, Dr. Centeno explains the critical questions patients should ask before getting any neck injections. The discussion breaks down the five skill and technology levels of cervical spine injection providers—from outdated blind techniques to advanced, image-guided, upper-cervical procedures. Learn how to evaluate safety, precision, and provider expertise to ensure your treatment matches the complexity of your condition and minimizes risk.
Centeno-Schultz Clinic - Podcasts
This episode of the CCI Deep Dive Podcast examines one of the most aggressively marketed—and most misunderstood—areas in regenerative medicine: umbilical cord, amniotic, and placental “stem cell” products. Drawing from published scientific investigations, the discussion breaks down why many of these birth-derived products do not contain functional living stem cells despite bold clinical claims. The episode walks listeners through the hard data, the extremely low viability rates (35–75%)...
